Nano-X Imaging (NNOX) Gross Margin (2022 - 2026)
Nano-X Imaging (NNOX) posted quarterly Gross Margin of 60.03% for Q1 2026, up 4828.0% year-on-year from 1.22% in Q1 2025, and up 38.27% on a QoQ basis from 97.26% in Q4 2025.
Nano-X Imaging (NNOX) Gross Margin (2022 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Gross Margin for 5 consecutive years, with 60.03% the latest figure, recorded in Q1 2026.
- Quarterly Gross Margin rose 4828.0% year-over-year to 60.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 84.91% (up 1560.0% YoY) and the FY2025 annual result came in at 98.21%, down 418.0% from the prior year.
- Gross Margin grew to 60.03% in Q1 2026 per NNOX's latest filing, from 97.26% in the prior quarter.
- Over the last five years, Gross Margin for NNOX reached as high as 59.84% in Q3 2022 and fell as low as 108.31% in Q1 2025.
- A 5-year average of 83.83% and a median of 81.94% in 2022 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2024 — Gross Margin sank 4021 bps — and 2026, when it soared 4828 bps.
- Year by year, Gross Margin stood at 81.94% in 2022, then advanced by 13 bps to 71.59% in 2023, then tumbled by 35 bps to 96.33% in 2024, then declined by 1 bps to 97.26% in 2025, then jumped by 38 bps to 60.03% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 60.03%, 97.26%, and 83.61% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | -60.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.03% |
| Dec 31, 2025 | -97.26% |
| Sep 30, 2025 | -83.61% |
| Jun 30, 2025 | -106.58% |
| Mar 31, 2025 | -108.31% |
| Dec 31, 2024 | -96.33% |
| Sep 30, 2024 | -92.77% |
| Jun 30, 2024 | -105.71% |
| Mar 31, 2024 | -80.45% |
| Dec 31, 2023 | -71.59% |
| Sep 30, 2023 | -67.04% |
| Jun 30, 2023 | -65.49% |
| Mar 31, 2023 | -62.24% |
| Dec 31, 2022 | -81.94% |
| Sep 30, 2022 | -59.84% |
| Jun 30, 2022 | -79.77% |
| Mar 31, 2022 | -106.14% |